Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-247 Cr₹-363 Cr₹35 Cr₹-186 Cr₹-251 Cr

What is the latest Cash Flow from Financing Activities ratio of NATCO PHARMA ?

The latest Cash Flow from Financing Activities ratio of NATCO PHARMA is ₹-247 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-247 Cr
Mar2023₹-363 Cr
Mar2022₹35 Cr
Mar2021₹-186 Cr
Mar2020₹-251 Cr

How is Cash Flow from Financing Activities of NATCO PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-247 Cr
Negative
Mar2023 ₹-363 Cr
Negative
Mar2022 ₹35 Cr
Positive
Mar2021 ₹-186 Cr
Negative
Mar2020 ₹-251 Cr -

Compare Cash Flow from Financing Activities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,808.9 Cr 10.7% 5.9% -15.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,136.0 Cr 6% 4% 9.9% Stock Analytics
DIVIS LABORATORIES ₹149,680.0 Cr 4.7% 0.3% 52.4% Stock Analytics
CIPLA ₹122,390.0 Cr 7% 3.7% 7.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,159.0 Cr 4.1% 6.4% 25% Stock Analytics
DR REDDYS LABORATORIES ₹97,105.6 Cr 6.3% 5% -4.7% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

10.7%

5.9%

-15.1%

SENSEX

5.8%

6.1%

4.7%


You may also like the below Video Courses